Pharmacogenomic testing for statin dosage helps personalise cholesterol-lowering therapy. Statins are widely used to lower cholesterol and reduce the risk of cardiovascular disease, but individual responses vary. Genetic testing can identify individuals at increased risk of statin-related side effects, such as muscle pain or liver damage. By analysing the SLCO1B1 gene, which influences statin transport and metabolism, this test helps optimise treatment plans for better cholesterol management with fewer complications.
Home / Tests Services / Pharmacogenomics
Pharmacogenomics · Sanger Sequencing
Statin Mutation Testing
SLCO1B1 variants that predict statin side effects.
Drop a photo for this test
or browse files
Overview
This test is offered for informational and preventive-health purposes. Results should be interpreted by a qualified healthcare professional alongside your clinical history, and do not by themselves constitute a medical diagnosis.
TEST DETAILS
Statin Mutation Testing
| Method | Sanger Sequencing |
|---|---|
| Gene Analysed | SLCO1B1 |
| Sample Type | Blood |
| Container | EDTA Tube |
| Sample Volume | 3–5 mL |
| Turnaround Time | 7 Days |
Expert result consultation included
Related tests.
View all 13 tests →WARF
Pharmacogenomics
CYP2C9 and VKORC1 variants for safer anticoagulant dosing.
Book a test
Request a callback.
Our clinical nutrition team will confirm suitability, explain sample collection, and book your slot.
✉
EMAIL
☎
PHONE
📍
VISIT
Flat No. 02, Shivam Apartment, Behind New Era English School, Govind Nagar, Nashik, MH-422009
We reply within one working day. Your details stay confidential.
Diagnostic testing is offered for informational and preventive-health purposes and does not constitute medical diagnosis or treatment. Always consult a qualified healthcare professional before making clinical decisions.